Korro Bio, Inc.

Healthcare · Biotechnology · United States

Last price 14.315 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 210.80M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company’s lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson’s disease, Amyotrophic lateral sclerosis, severe d...